SCHEMBL8623711

SCHEMBL8623711

CS(=O)(=O)Nc1cc2c(cc1Oc1ccccc1)C(=O)CC2

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 19/20 0.75
PTGS1 P23219 4/20 0.50
ADORA3 P0DMS8 2/20 0.50
KDM4E B2RXH2 1/20 0.50
MEN1 O00255 1/20 0.50
MLNR O43193 1/20 0.50
LMNA P02545 1/20 0.50
MMP1 P03956 1/20 0.50
MPO P05164 1/20 0.50
CYP1A2 P05177 1/20 0.50
GLA P06280 1/20 0.50
CYP3A4 P08684 1/20 0.50
MAPT P10636 1/20 0.50
CYP19A1 P11511 1/20 0.50
CYP2C9 P11712 1/20 0.50
HPGD P15428 1/20 0.50
TSHR P16473 1/20 0.50
TBXA2R P21731 1/20 0.50
SLC6A2 P23975 1/20 0.50
APEX1 P27695 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11176934 0.95 PTGS2 (0.68) PTGS2PTGS1ADORA3KDM4EMEN1
SCHEMBL11182826 0.88 PTGS2 (0.76) PTGS2PTGS1
SCHEMBL11186397 0.88 PTGS2 (0.76) PTGS2PTGS1
SCHEMBL11181115 0.87 PTGS2 (0.65) PTGS2PTGS1
SCHEMBL11189224 0.86 PTGS2 (0.58) PTGS2PTGS1ADORA3KDM4EMEN1
SCHEMBL11177588 0.84 PTGS2 (0.81) PTGS2PTGS1
SCHEMBL11176910 0.83 PTGS2 (0.54) PTGS2PTGS1ADORA3KDM4EMEN1
SCHEMBL11176908 0.83 PTGS2 (0.54) PTGS2PTGS1ADORA3KDM4EMEN1
SCHEMBL11180756 0.82 PTGS2 (0.53) PTGS2PTGS1ADORA3KDM4EMEN1
SCHEMBL11180753 0.82 PTGS2 (0.53) PTGS2PTGS1ADORA3KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0009554-B1 INDANYL DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS SCHERING AKTIENGESELLSCHAFT (DE) 1983-04-27 EP claimed
US-4244960-A HERBICIDES OR ANTIINFLAMMATORY AGENTS SCHERING, AKTIENGESELLSCHAFT (DE) 1981-01-13 US claimed
EP-0009554-A1 Indanyl derivatives, process for their preparation and pharmaceutical compositions containing these compounds SCHERING AKTIENGESELLSCHAFT (DE) 1980-04-16 EP claimed
US-5811416-A ADMINISTERING TO TREAT DISORDERS SUCH AS DYSMENORRHEA, PRETERM LABOR, PREECLAMPSIA, OR FETAL GROWTH RETARDATION; ALSO HORMONE REPLACEMENT THERAPY, HYPERTENSION BOARD OF REGENTS THE UNIVERSITY OF TEXAS SYSTEM (US) 1998-09-22 US disclosed
EP-0844884-A2 ENDOTHELIN ANTAGONISTS AND ENDOTHELIN SYNTHASE INHIBITORS FOR THE PREVENTION AND TREATMENT OF UTERINE CONTRACTILITY DISORDERS, PREECLAMPSIA, ATHEROSCLEROTIC VASCULAR DISEASE, HYPERTENSION AND FOR HORMONE REPLACEMENT THERAPY CHWALISZ, Krzysztof (DE) 1998-06-03 EP disclosed
WO-1996035453-A2 ENDOTHELIN ANTAGONISTS AND ENDOTHELIN SYNTHASE INHIBITORS FOR THE PREVENTION AND TREATMENT OF INTERINE CONTRACTILITY DISORDERS, PREECLAMPSIA, ATHEROSCLEROTIC VASCULAR DISEASE, HYPERTENSION AND OR HORMONE REPLACEMENT THERAPY CHWALISZ KRISTOF (DE) 1996-11-14 WO disclosed
EP-0143403-B1 PROCESS FOR THE PREPARATION OF INDANE DERIVATIVES, AND THEIR USE SCHERING AKTIENGESELLSCHAFT (DE) 1991-04-10 EP disclosed
US-4696948-A ANTIINFLAMMATORY AGENTS, ANTIALLERGENS SCHERING AKTIENGESELLSCHAFT (DE) 1987-09-29 US disclosed
EP-0143403-A2 Process for the preparation of indane derivatives, and their use SCHERING AKTIENGESELLSCHAFT (DE) 1985-06-05 EP disclosed
EP-0009554-B1 INDANYL DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS SCHERING AKTIENGESELLSCHAFT (DE) 1983-04-27 EP disclosed
US-4244960-A HERBICIDES OR ANTIINFLAMMATORY AGENTS SCHERING, AKTIENGESELLSCHAFT (DE) 1981-01-13 US disclosed
EP-0009554-A1 Indanyl derivatives, process for their preparation and pharmaceutical compositions containing these compounds SCHERING AKTIENGESELLSCHAFT (DE) 1980-04-16 EP disclosed